Diabetes mellitus induces a novel inflammatory network involving cancer progression: Insights from bioinformatic analysis and in vitro validation
Authors:
Open Access
- 23 March 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14
Abstract
Background: Patients with diabetes mellitus (DM) have a higher incidence of malignant tumors than people without diabetes, but the underlying molecular mechanisms are still unclear.Methods: To investigate the link between DM and cancer, we screened publicly available databases for diabetes and cancer-related genes (DCRGs) and constructed a diabetes-based cancer-associated inflammation network (DCIN). We integrated seven DCRGs into the DCIN and analyzed their role in different tumors from various perspectives. We also investigated drug sensitivity and single-cell sequencing data in colon adenocarcinoma as an example. In addition, we performed in vitro experiments to verify the expression of DCRGs and the arachidonic acid metabolic pathway.Results: Seven identified DCRGs, including PPARG, MMP9, CTNNB1, TNF, TGFB1, PTGS2, and HIF1A, were integrated to construct a DCIN. The bioinformatics analysis showed that the expression of the seven DCRGs in different tumors was significantly different, which had varied effects on diverse perspectives. Single-cell sequencing analyzed in colon cancer showed that the activity of the DCRGs was highest in Macrophage and the lowest in B cells among all cell types in adenoma and carcinoma tissue. In vitro experiments showed that the DCRGs verified by western bolt and PEG2 verified by ELISA were all highly expressed in COAD epithelial cells stimulated by high glucose.Conclusion: This study, for the first time, constructed a DCIN, which provides novel insights into the underlying mechanism of how DM increases tumor occurrence and development. Although further research is required, our results offer clues for new potential therapeutic strategies to prevent and treat malignant tumors.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81873169)
This publication has 68 references indexed in Scilit:
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Intestinal mucosal MMP-1 – a prognostic factor in colon cancerScandinavian Journal of Gastroenterology, 2013
- The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patientsInternational Journal of Colorectal Disease, 2010
- Diabetes Mellitus Type 2 – An Independent Risk Factor for Cancer?Experimental and Clinical Endocrinology & Diabetes, 2010
- Survivin, cancer networks and pathway-directed drug discoveryNature Reviews Cancer, 2008
- A cytokine-mediated link between innate immunity, inflammation, and cancerJournal of Clinical Investigation, 2007
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancerJournal of Experimental Medicine, 2006
- Free radicals, metals and antioxidants in oxidative stress-induced cancerChemico-Biological Interactions, 2006
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002